News UK 'needs more transparency on pharma-doctor payments' The UK's system of disclosing payments from pharma to healthcare professionals has gaps that hide potential conflicts of interest, claims study.
Debates & Insight Sponsored Digital health: how can technology be used to engage hard-to... Helping someone live with a condition as complex as MS can be fraught with challenges.
Views & Analysis Behavioural science + medical education: a transformative co... ‘We need to walk in the shoes of HCPs and patients if we are to design programmes that improve health outcomes.’
R&D On genomics, NGS, and doing much more good than bad, with Ma... Markus Vossman, Germany general manager at Illumina, discusses innovative genomic applications and projects in the region.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.